Human Papillomavirus (HPV) Detection, High Risk with Genotyping
Remarks:Vaginal specimens are not preferred.
- Frozen specimens
- Swabs or samples in any other transport media
- Thin Prep® or PreservCyt®: Three weeks at 15° - 30° C
- Detecting the presence of high-risk HPV DNA and determining the specific genotype (HPV 16, HPV 18 or other high-risk HPV (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68)
- This test helps fulfill the new ACS, ASCCP and ASCP screening guidelines for Pap tests.
The Aptima HPV assay is a transcription-based nucleic acid amplification method with detection by the Hybridization Protection Assay (HPA) using the Panther System.
4 days from receipt of the specimen
Monday through Friday
The Aptima HPV assay is an in vitro nucleic acid amplification test for the qualitative detection of E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The high-risk HPV types detected by the assay include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.
- HPV 16 : Result
- HPV 18/45 : Result
|Positive (detected)|| Corresponding HPV
|Negative (not detected)|| Corresponding HPV
was not detected.
|Invalid|| A valid result
was not obtained.